Login to My NLA Account

“I sometimes joke that if you come to our hospital missing a finger, no one will believe you until we get a CAT scan, an MRI and an orthopedic consult. We just don’t trust our senses.” ~ Dr. Abraham Verghese

Article By:

JAMES A. UNDERBERG, MD, MS, FACPM, FACP, FNLA
Clinical Assistant Professor of Medicine
NYU School of Medicine & NYU Center for Prevention of Cardiovascular Disease
Director Bellevue Hospital Lipid Clinic
New York, NY
Diplomate, American Board of Clinical Lipidology

 

0
No votes yet

Dr. Rosenblit: I am honored to serve as President of the NLA’s Pacific Lipid Association (PLA) Chapter. The PLA membership and its board represent diversity of thought and expertise, but our unity lies in an enthusiasm for atherosclerosis prevention through lipid management.

Article By:

PAUL D. ROSENBLIT, MD, PhD, FACE, FNLA
President, Pacific Lipid Association
Clinical Professor, Medicine, Division Endocrinology, Diabetes, and Metabolism
UC Irvine, School of Medicine
Co-Director, Diabetes Out-Patient Clinic, UCI Medical Center
Director & Principal Investigator, Diabetes/Lipid Management & Research Center
Orange County, CA
Diplomate, American Board of Clinical Lipidology
B ALAN BOTTENBERG, DO, FACOI, FNLA
Immediate Past President, Pacific Lipid Association
Northern Nevada Lipidology
Carson City, NV
Diplomate, American Board of Clinical Lipidology
0
No votes yet

I am honored and truly humbled to have the opportunity to serve as the President of the National Lipid Association (NLA) during the 2014/2015 term. In just a few months as president, I’ve seen tremendous strides in the lipid community, which I only hope to continue during the remainder of my term. The initiative taken by members of the NLA and its board during the past year and beyond is not only encouraging — but deeply appreciated.

Article By:

TERRY A. JACOBSON, MD, FACP, FNLA
National Lipid Association President
Professor of Medicine, Emory University
Atlanta, GA
Director, Lipid Clinic and Cardiovascular Risk Reduction Program
Diplomate, American Board of Clinical Lipidology
5
Average: 5 (1 vote)
Last Updated: Thursday, 31-Jul-2014 16:00:00 EDT

From University of Miami: For Carl E. Orringer, M.D., the newest faculty member in the Cardiovascular Division, the move from Cleveland to Miami is a homecoming. Orringer is a triple ’Cane, with a B.A. in chemistry (1970), an M.D. (1974) and a residency at Jackson Memorial Hospital (1977). Thirty-seven years later, he’s back, bringing with him a high-profile cardiovascular disease-prevention program that he developed.

“Everything is coming full circle,” Orringer said. “I feel an allegiance to UM, and bringing the program here is my way of saying thank you.”

Last Updated: Wednesday, 30-Jul-2014 16:00:00 EDT

The 2013 Impact Factors were recently released and the Journal of Clinical Lipidology (JCL) saw a significant increase — from 2.741 (2012) to 3.587. The Journal is now ranked 53rd out of 254 journals in its category (pharmacology and pharmacy). 

Last Updated: Wednesday, 30-Jul-2014 04:00:00 EDT

The National Lipid Association is sad to report that Gumaro Garza, MD, an active member of the Southwest Lipid Association, passed away July 29, 2014, after suffering a myocardial infarction and subsequent cardiogenic shock. Garza resided in Edinberg, Texas, and was very active in the treatment of dyslipidemia in the Mexican-American population. He is survived by his ex-wife, Christine Garza, PhD, who is also a member of the SWLA chapter, and his daughter.

Last Updated: Friday, 18-Jul-2014 16:00:00 EDT

The results of the HPS2-THRIVE study were released in the New England Journal of Medicine on July 17, 2014. Also, appearing in the same edition was a special correspondence from the AIM HIGH investigators concerning further analysis of adverse events, and an editorial addressing both of these publications.

Last Updated: Monday, 09-Jun-2014 16:00:00 EDT

Statins play a critical role in reducing the risk of heart disease. Not only are the benefits greatly appreciated by both physicians and patients, the majority of statins are also well tolerated. Despite this, many patients discontinue statin therapy against medical advice, oftentimes without notifying their doctors. For this reason, the National Lipid Association embarked on a study that used internet surveys to determine why patients discontinue their statins.

Last Updated: Monday, 09-Jun-2014 16:00:00 EDT